I understand that Epitan has met with the US FDA for phase III approval. Surely Epitan must have submitted their phase II results to support this application. It will be interesting to see if they announce approval for a III before they announce a sucsessful II (due early Nov), since it stands to reason that a positive announcement for a III will depend on a sucsessful II. So...... Perhaps they will announce the two on the same day. Both in early Nov- a big week indeed if it pans out that way!
Stolwyk what do you think?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $7.461M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $6.972K | 1.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1125473 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 14157931 | 16 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| TMS (ASX) Chart |